The UK Drugs in Lactation Advisory Service has reviewed the FDA statement (Issued April 2017) regarding contra-indicating tramadol use during the breastfeeding period.
Despite the FDA warning, tramadol can continue to be used (with caution) during breastfeeding. Always use the lowest effective dose for the shortest time possible.
Infants should be monitored for increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties or limpness, and constipation; contact a physician immediately if any of these occur.
For further details, refer to the attached review.
Regional Principal Medicines Information Pharmacist, Trent Medicines Information Service & UK Drugs in Lactation Advisory Service